Published Date: 15 Mar 2023
A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.
Read Full NewsFrank Sciurba, MD, reports tozorakimab improved E-RS:COPD scores vs placebo at week 52 in OBERON and TITANIA, including breathlessness and chest symptoms.
Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD
Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.
Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, its growing year-round presence, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.
The Editor-in-Chief of the Journal of the American Heart Association discussed what journal editors look for in stroke research submissions, how AI and open access are reshaping publishing, and the equity gaps that still exist for researchers in lower-income countries.
Mitzi Joi Williams, MD, is joined by Temitope Adeola, MD, and Chantale Branson, MD, to discuss migraine as a complex neurological condition, including recognizing symptoms and triggers, navigating acute and preventive treatment options, and incorporating lifestyle modifications to improve migraine management.
A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.
1.
Breast cancer: A new target to eliminate dormant cells before they wake
2.
A Surgical First for Removal of an Appendiceal Neoplasm
3.
New tumor therapy approach reduces costs and side effects while increasing accessibility
4.
Veterans of the Navy have high lung cancer rates associated with asbestos use.
5.
Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation
1.
The Lung Cancer Shift: From Reactive Treatment to Proactive Precision Medicine
2.
Neonatal Hematopoietic Transition and Blood Cell Maturation
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
5.
Women's Cancer Survivorship: Emerging Long-Term Health Priorities
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Cancer Staging Education Through Interactive Anatomical Spread Maps
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation